Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, atrial fibrillation ablation and other structural heart procedures.

Latest News

Share this

KSH @ TCT2018 Symposium

We invite you to explore and discuss with world-renown physicians the importance of complete cerebral embolic protection with TAVR. Please join us for the Keystone Heart Lunch Symposium during TCT 2018 where we will share current research on cerebral embolic debris during TAVR, progress of the US REFLECT trial using TriGUARD 3™,
and early US experience with the new TriGUARD 3 technology.

If you have interest in meeting with Keystone Heart Executives, contact Dave Nevrla, Global Marketing Director,

The Case for Complete Cerebral Embolic Protection – REFLECT
Saturday, September 22, 2018
Program: 1:00 pm-2:00 pm
Presentation Theater 4 (Exhibit Hall)
San Diego Convention Center




Alexandra Lansky, MD, Yale School of Medicine

Tamim Nazif, MD, Columbia University Medical Center


Abhijeet Dhoble, MD, McGovern Medical School University of Texas Health Science Center

Darius Dudek, MD, PhD, Krakow University Hospital, Krakow, Poland

John Forrest, MD, Yale School of Medicine

Michael Mack, MD, The Heart Hospital Baylor Plano

Raj Makkar, MD, Cedars-Sinai Medical Center

Jeffrey Moses, MD, Columbia University Medical Center

Joachim Schofer, MD, Albertinen Cardiovascular Centre

Rahul Sharma, MD, Cedars-Sinai Medical Center


1:00 pm Current Cerebral Embolic Protection Landscape – Keystone Heart TriGUARD Data Review – Jeffrey Moses

1:10 pm REFLECT Clinical Update with TriGUARD 3 – Tamim Nazif

1:20 pm TriGUARD 3 Case Presentation– Early US Experience – Michael Mack

1:28 pm TriGUARD 3 Post-Market EU Registry Plan – Darius Dudek

1:35 pm The Importance of DW-MRI and Longitudinal Impact of Cerebral Ischemic Lesions – John Forrest

1:45 pm Cerebral Embolic Protection Panel Discussion – Alexandra Lansky

2:00 pm Adjourn



No Comments

Leave a reply